MSD and Mayo Clinic team up on AI drug discovery
MSD has signed an industry-first deal with the Mayo Clinic that will allow it to use the health system's genomic and clinical data for drug discovery.
Newsletters and Deep Dive digital magazine
MSD has signed an industry-first deal with the Mayo Clinic that will allow it to use the health system's genomic and clinical data for drug discovery.
A report has found that the number of life sciences companies domiciled in the UK has grown by nearly a quarter in the last few years.
Novartis is set to expand the label for its oral BTK inhibitor Rhapsido, keeping the drug on course to become one of its biggest-ever brands.
January was a relatively quiet month for Board news, but there were some notable moves here and there.
Volunteers with schizophrenia, bipolar, and depression will take part in an NHS study that will use genetic and health data to find new therapies.
Editor's Picks
Newsletters and Deep Dive
digital magazine